J
James Mirocha
Researcher at Cedars-Sinai Medical Center
Publications - 243
Citations - 7647
James Mirocha is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Transplantation & Medicine. The author has an hindex of 45, co-authored 225 publications receiving 6497 citations. Previous affiliations of James Mirocha include University of Southern California.
Papers
More filters
Journal ArticleDOI
Comparison of effectiveness of hand-carried ultrasound to bedside cardiovascular physical examination.
Sergio Kobal,Luca Trento,Simin Baharami,Kirsten Tolstrup,Tasneem Z. Naqvi,Bojan Cercek,Yoram Neuman,James Mirocha,Saibal Kar,James S. Forrester,Robert J. Siegel +10 more
TL;DR: The diagnostic accuracy of medical students using an HCU device after brief echocardiographic training to detect valvular disease, left ventricular dysfunction, enlargement, and hypertrophy was superior to that of experienced cardiologists performing cardiac physical examinations.
Journal ArticleDOI
Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life.
TL;DR: This study indicates that the asymptomatic female carrier of Fabry disease is the exception, not the rule: heterozygotes suffer from significant multisystemic disease and reduced quality of life and must be monitored and treated accordingly.
Journal ArticleDOI
Clinical Profile and Predictors of Complications in Peripartum Cardiomyopathy
Sorel Goland,Kalgi Modi,Fahed Bitar,Munir Janmohamed,James Mirocha,Lawrence S.C. Czer,Sandra Illum,Parta Hatamizadeh,Uri Elkayam +8 more
TL;DR: Significant predictors of MAE were left ventricular ejection fraction
Journal ArticleDOI
Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients.
Nancy L. Reinsmoen,Chih-Hung Lai,Harald Heidecke,Mark Haas,Kai Cao,Geraldine Ong,Mehrnoush Naim,Qi Wang,James Mirocha,Joseph Kahwaji,Ashley Vo,Stanley C. Jordan,Duska Dragun +12 more
TL;DR: A strong association was observed between the presence of high binding to AT1R and AMR in recipients whose sera contained no antibody to donor HLA or MICA, and Assessing the At1R antibody status along with the HLA-DSA provides additional information to determine the immunologic risk for recipients.
Journal ArticleDOI
The Akt pathway in human breast cancer : a tissue-array-based analysis
TL;DR: A large proportion of in-situ and invasive breast cancers overexpressed cyclinD1 and S6, indicating association with disease progression and may have significant implications in the development and application of targeted therapy.